Increasing Demand For Minimally Invasive Angioplasty Treatments Driving Global Interventional Cardiology And Peripheral Vascular Devices Market

Factors such as the aging population, rising incidence of cardiovascular diseases, increasing demand of minimally invasive procedures, and technological advancements are expected to drive the growth of this market.The interventional cardiology market is expected to reach USD 31.47 Billion by 2021 from USD 21.83 Billion in 2016, at a CAGR of 7.1%.

Get PDF Brochure Here: http://bit.ly/2uDGzna

Key players :

The major players in the interventional cardiology market include Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic plc (U.S.), and Terumo Corporation (Japan).

About Report :

On the basis of type, the angioplasty stent market is segmented into drug-eluting stents, bare-metal stents, and bioabsorbable stents. On the basis of type, the catheters market is segmented into IVUS/OCT, angiography catheters, and guiding catheters. In 2016, the angiography catheters segment is expected to account for the largest share of the market.On the basis of type, the EVAR stent grafts market is segmented into abdominal aortic aneurysms and thoracic aortic aneurysms. In 2016, the abdominal aortic aneurysms segment is expected to account for the largest share primarily due to the rising incidence of smoking and hypertension.

Value Addition for the Buyer:

This report aims to provide insights into the global interventional cardiology & peripheral vascular devices market. It provides valuable information on interventional cardiology & peripheral vascular devices product segment and end user. Details on regional markets for these segments are also presented in this report. In addition, leading players in the market are profiled to understand the strategies undertaken by them to be competitive in this market.

To Know More About It: http://bit.ly/2uE8eog 

Increasing Demand For Standard-Based Medical Image Archiving And Non-Dicom Content Management | Driving Vendor Neutral Archive (VNA) Market

Get PDF Brochure Here : http://bit.ly/2hqdozC

Vendor Neutral Archive (VNA) Technology Benefits :

VNAs enable the acquisition, management, and storage of images while streamlining the communication between multiple vendor PACS. while streamlining the communication between multiple vendor  Picture Archiving And Communications System (PACS).

The global VNA market is poised to reach $335 million by 2018, at a healthy double-digit CAGR; whereas, the PACS market is growing at a steady CAGR of 5.8%, to reach $4.3 billion by 2018.

About Report :

The VNA market is segmented on the basis of its delivery mode, deployment model, and supplier type. In the delivery mode segment, on-premise VNA forms the largest segment of the overall VNA market, as on premise VNAs are perceived to offer better control and secure sharing of data. However, Hybrid VNA will be the fastest growing and consequently a new revenue generating segment for players in this market. Hybrid VNAs allow the cloud to store all the second copies of images, thereby significantly reducing the cost of disaster recovery.

The Major Factor Driving Growth :

A number of factors such as the presence of favorable government regulations for top markets and the growing demand for standard based storage, disaster recovery, and lifecycle management solutions are propelling the growth of the market for VNAs. Consolidation of patient information by integrating VNAs with electronic health records (EHR) is one of the important trends witnessed in this market

To Know More : http://bit.ly/2uZ5ykU

Healthcare Quality Management Software: Market Overview

The Major Factor For The Market Growth :

Government mandates for healthcare providers to report quality & improve the performance of care provided, rising healthcare costs, high rate of medication errors, growing need to minimize hospital readmissions, and increase in the volume of unstructured data in the healthcare industry are the major factors driving the growth of the market.

Get PDF Brochure Here : http://bit.ly/2wrejCk

The global healthcare quality management market is projected to reach USD 3.31 billion by 2022 from an estimated USD 1.70 billion in 2017, at a CAGR of 14.2%.

On the basis of type, the business intelligence & analytic solutions segment is the fastest-growing segment during the forecast period. The soaring operating costs, rising demand for quality healthcare, government measures to promote value-based care, and the increasing number of claims denied from insurers are the major factors driving the growth of the business intelligence & analytic solutions segment.

By delivery mode, the global healthcare quality management market is segmented into web-& cloud-based and on-premise solutions. In 2016, the web-& cloud-based solutions segment dominated the healthcare quality management market. This segment is also expected to grow at the highest CAGR during the forecast period. The flexibility of working from remote areas, affordability, and automated updating features are some of the factors attributing to the high growth of the web- & cloud-based solutions segment.

On the basis of application, the market is categorized into data management and risk management. In 2016, the data management segment accounted for the largest share of the healthcare quality management market. The large share of this segment is attributed to the increasing volume of disparate data and the requirement of quality-based reports by regulatory bodies. The data management segment is further divided into unstructured data abstraction, data processing & analysis, report generation, and report submission. In 2016, the data processing & analysis segment accounted for the highest share of the data management market. The large share of this segment is mainly attributed to the high volume of unwanted data generation by healthcare facilities and growing need to structure & analyze data in a standardized format for quality reporting.

North America is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the growing healthcare IT spending, developed infrastructure, evolving regulations for better healthcare outcomes, and the presence of prominent market players in this region.

To Know More : http://bit.ly/2wdqJOY

Increasing Focus on Personalized Medicine to Boost the Nuclear Imaging Market Growth

The report"Nuclear Imaging Equipment Market by Product (SPECT (Hybrid SPECT, Standalone SPECT), Hybrid PET, & Planar Scintigraphy), Application (Oncology, Cardiology & Neurology) & End user (Hospitals, Imaging Centers) - Global Forecasts to 2021", that analyzes and studies the major market drivers, restraints/challenges, and opportunities.

This report studies the global nuclear imaging equipment market for the forecast period of 2016 to 2021. This market is expected to reach USD 2.85 Billion by 2021 from USD 2.25 Billion in 2016, growing at a CAGR of 4.8%.

The global nuclear imaging equipment market is segmented on the basis of product, application, end user, and region.

Based on product, the nuclear imaging equipment market is categorized into SPECT systems, hybrid PET systems, and planar scintigraphy.

 In 2016, the SPECT systems segment is expected to account for the largest share of the nuclear imaging equipment market. The SPECT systems are further segmented into hybrid SPECT and standalone SPECT systems. In 2016, the hybrid SPECT segment is expected to account for the largest share of the SPECT nuclear imaging equipment market. Advantages such as better imaging ability, high resolution, and the ability to show molecular processes in vivo render hybrid SPECT systems superior than standalone systems.

Get PDF Brochure Here : http://www.marketsandmarkets.com/pdfdownload.asp?id=98

Based on application, the nuclear imaging equipment market is segmented into oncology, cardiology, neurology, and other applications (orthopedics, urology, thyroid-related disorders, and gastroenterology). In 2016, the oncology application segment is expected to account for the largest share of the nuclear imaging equipment applications market. The rising incidence and prevalence of cancer across the globe, initiatives taken by public and private organizations to curb the same, and development of advanced systems and radiotracers for oncology are the key factors contributing to the large share of the oncology segment.

Based on end user, the nuclear imaging market is segmented into hospitals, imaging centers, academic & research centers, and other end users (pharmaceutical & biotechnology companies and CROs). In 2016, the hospitals segment is expected to account for the largest share of the market. The rise in the use of advanced imaging solutions and hybrid imaging systems in hospitals and enhanced care quality is driving the growth of this segment.

Based on region, the nuclear imaging equipment market is divided into North America, Europe, Asia-Pacific, and Rest of the World (RoW). The RoW region comprises Latin America, the Middle East and Africa. In 2016, North America is projected to account for the largest share of the nuclear imaging equipment market, followed by Asia-Pacific and Europe. Increase in adoption of nuclear imaging technologies and rapid growth in aging population, along with high incidence and prevalence of chronic diseases, are propelling the growth of the North American nuclear imaging equipment market.

Factors driving the global market include introduction of new and advanced products, investment for the modernization of diagnostic imaging centers, development of new radiotracers, and increasing incidence and prevalence of cancer & cardiovascular diseases. However, factors such as shutdown of National Research Universal (NRU) reactor, high cost of nuclear imaging equipment, and shorter half-life of radiopharmaceuticals are hindering the growth of the market.

Get Request Sample Here : http://www.marketsandmarkets.com/requestsample.asp?id=98

The major players in the global nuclear imaging equipment market are Siemens Healthineers (Germany), Philips Healthcare (Netherlands), and GE Healthcare (U.S.).These companies are dominant in the nuclear imaging market mainly due to their well-established presence in the field of medical imaging, presence in over 50 countries, high R&D investments, and strong sales and distribution force.

 The other players in the market include Toshiba Medical Systems Corporation (Japan), Neusoft Medical Systems Co., Ltd. (China), Mediso Medical Imaging Systems Ltd. (Hungary), Digirad Corporation (U.S.), CMR Naviscan Corporation (U.S.), SurgicEye GmbH (Germany), and DDD Diagnostics (Denmark).

Attractive Growth Opportunities in Orthopedic Software Market During 2012–2020

Factors Which Are Driving Orthopedic Software Market 

Growing aging population, upsurge in the number of orthopedic surgeries, and rising incidences of orthopedic problems such as arthritis and osteoporosis are some of the factors propelling the growth of this market. Rising incidences of lifestyle disorders like obesity is another factor leading to orthopedic problems among patients, which is further expected to aid the growth of this market.

The orthopedic software market is expected to grow at a CAGR of 5.1% from 2014 to 2020 to reach $308.5 million by 2020.

Get PDF Brochure Here : http://bit.ly/2vRKTks

Key players :

Materialise NV (Belgium), Merge Healthcare Inc. (U.S.), Brainlab AG (Germany), CureMD (U.S.), HealthFusion Inc. (U.S.), Medstrat, Inc. (U.S.), McKesson Corporation (U.S.), and Greenway Health (U.S.) are some of the leading players in this market.

Market Geography:

The North American market accounted for the largest share of the global market in 2014, followed by Europe, Asia-Pacific, and Rest of the World (RoW). This is mainly due to the relatively high penetration of orthopedic software in North America as compared to Europe, Asia-Pacific and RoW. However, Asia-Pacific region is expected to register highest growth during the forecast period owing to increasing acceptance of healthcare IT in this region. China and Japan are some of the countries that are expected to contribute to the growth of this region.

About Report :

The global market is broadly segmented into products, applications, and mode of delivery. By type of products, this market is mainly sub-segmented into pre-operative planning software, orthopedic EHR, practice management, orthopedic picture archiving and communication systems (PACS), and orthopedics revenue cycle management (RCM). The market by applications covers orthopedic surgeries, joint replacement, fracture and limb deformity management, and pediatric assessment; while the market by mode of delivery covers web-based, cloud based, and on premises systems.

To Know More : http://bit.ly/2vHb5ho

HIP Replacement Market worth 5.9 Billion USD by 2020

This global hip reconstruction devices market is analysed and segmented on the basis of product, and region. It analyzes the competitive developments, such as alliance, joint venture, and mergers & acquisitions in the global market. This market is also analyzed with an explicit focus on the high-growth applications and fastest-growing market segments.

A hip replacement is an invasive surgical procedure, used to remove a diseased or fractured hip joint and replace it with an artificial joint or prosthesis. Osteoarthritis is one of the most common factors for hip diseases. Structures within the hip (such as the cartilage or bony joint surfaces) may get damaged due to overuse, trauma, or certain conditions, such as rheumatoid arthritis, tumors, and so on. This may lead to degenerative changes within the hip which can lead to 

osteoarthritis.

Get PDF Brochure Here : http://bit.ly/2wS7j2k

Some of the significant factors of the MIS are reduced hospital stay, as well as shortened rehabilitation time. Also, the increasing number of patients suffering from osteoarthritis, rheumatoid arthritis, and osteoporosis have led to increase in the adoption rate of hip surgeries in both geriatric as well as young population. Out of 66 million population of France, about 3% of the population is aged above 65 years, and has undergone hip replacement/reconstruction.

The global hip reconstruction devices market was valued at USD 4.8 Billion in 2014 and is expected to reach USD 5.9 Billion by 2020, at a CAGR of 3.0% from 2015-2020.

The hip reconstruction devices market is broadly segmented on the basis of product and geography. Based on product, the global market is classified into primary, partial, revision and hip resurfacing devices. The primary is subsegmented into cementless and cemented reconstruction device. The primary devices commands the largest share in the market, by product.

The report provides a detailed analysis of hip reconstruction devices market for each region and country. Four major regions have been covered in the report, such as North America (the U.S., Canada, Mexico, Brazil, Argentina, Chile, Columbia, Uruguay and Paraguay); Europe (Germany, France, Italy, Spain, Switzerland, the U.K., Netherlands, Belgium, Denmark, Turkey, and Russia); and Asia-Pacific (Japan, China, India, Australia, Republic of Korea, Singapore, Malaysia, New Zealand, Vietnam, Indonesia, Taiwan, and Thailand). A deep-dive analysis on pricing pattern, usage pattern, end user response matrix, market share, government initiatives, product recalls, new product launches, industry trends, and technological advancements have been detailed in the report.

The report also covers the competitive landscape of global hip reconstruction devices market by new product launches, recent developments, and mergers & acquisitions. The major players operating in this market are Zimmer Inc. (U.S.), DePuy Synthes (U.S.), Stryker (U.K.), and Smith & Nephew (U.K.), B. Braun Melsungen AG (Germany), Corin (U.K.), and Waldemar LINK GmbH & Co. KG (Germany).

To Know More : http://bit.ly/2uKs4jk

Increasing Prevalence of Lifestyle Diseases | Driving Vascular Access Devices Market

The global vascular access devices market is expected to reach USD 5.45 billion by 2022 from USD 3.87 billion in 2017, at a CAGR of 7.1%.

The major drivers for the market

·         Growing prevalence of lifestyle diseases

·         An increase in the number of chemotherapy procedures

·         The increasing use of vascular access devices in pediatric patients.

Get PDF Brochure Here : http://bit.ly/2tYSEAL

The report analyzes the vascular access device market by type, application, end user, and region. The type segment includes central vascular access devices, peripheral vascular access devices, and accessories. The central vascular access devices segment is expected to account for the largest share of the vascular access devices market in 2017. The dominant share of the market is attributed to the fact that central vascular access devices are used in chemotherapy and for the treatment of cardiovascular disorders and chronic kidney disorders.

By type, the market segment is segmented into central vascular access devices, peripheral vascular access devices, and accessories. Central vascular access devices are expected to account for the largest share of the market in 2017. The growth of this segment is attributed to the wide usage of central vascular access devices in chemotherapy and for the treatment of cardiovascular disorders and chronic kidney disorders.

 Based on application, the market is broadly classified into drug administration, fluids and nutrition administration, blood transfusion, and diagnostics and testing. The drug administration segment is estimated to account for the largest share of the market in 2017, the growth of drug administration segment is attributed to the high usage of vascular access devices for drug administration for the treatment of infections, cancer, and other diseases.

Based on the end users, the market is segmented into hospitals, clinics and ambulatory care centers, and other end users. In 2017, the hospital segment is expected to dominate this market. The large share of this segment can be attributed to the fact that a majority of vascular procedures are performed in hospital settings.

To Know More : http://bit.ly/2f7R64N